🚀 VC round data is live in beta, check it out!
Largest HealthTech Public Companies
Benchmark revenue and EBITDA valuation multiples for public comps like
Johnson & Johnson, UnitedHealth Group, Siemens, Abbott and Thermo Fisher Scientific.
 | $240 | +45% | $577B | $605B | 6.3x | 17.1x | ||
| $295 | -44% | $267B | $317B | 0.7x | 11.9x | ||
 | $263 | +7% | $205B | $251B | 2.7x | 15.0x | ||
| $114 | -14% | $198B | $203B | 4.5x | 16.9x | ||
| $509 | +2% | $191B | $220B | 4.9x | 19.6x | ||
| $496 | +0% | $176B | $170B | 16.5x | 38.1x | ||
| $387 | +4% | $148B | $160B | 6.3x | 21.7x | ||
| $206 | +1% | $146B | $161B | 6.5x | 20.6x | ||
| $98 | +9% | $126B | $146B | 4.1x | 14.3x | ||
| $76 | -24% | $113B | $123B | 6.0x | 19.0x | ||
| $48 | -17% | $54B | $52B | 1.9x | 9.4x | ||
| $637 | +52% | $51B | $51B | 11.8x | 33.6x | ||
| $87 | +20% | $51B | $47B | 7.7x | 25.4x | ||
| $26 | +2% | $38B | $37B | 6.7x | 17.5x | ||
| $354 | -40% | $36B | $45B | 5.7x | 14.3x | ||
| $79 | -2% | $36B | $42B | 2.0x | 11.3x | ||
| $118 | +1% | $33B | $35B | 5.0x | 17.0x | ||
 | $27 | -21% | $33B | $30B | 5.9x | 17.1x | ||
| $307 | -17% | $30B | $31B | 8.2x | 24.0x | ||
| $181 | -22% | $30B | $23B | 7.2x | 15.8x | ||
| $174 | -1% | $30B | $43B | 2.6x | 11.3x | ||
 | $31 | +13% | $29B | $35B | 1.6x | 10.0x | ||
| $74 | +8% | $28B | $28B | 5.8x | 19.9x | ||
| $200 | +42% | $28B | $27B | 11.4x | (102.6x) | ||
| $1,325 | +12% | $27B | $29B | 7.1x | 22.9x | ||
| $248 | +9% | $24B | $26B | 4.4x | 15.2x | ||
| $286 | +23% | $24B | $30B | 2.1x | 12.2x | ||
| $210 | +24% | $23B | $29B | 2.6x | 13.2x | ||
| $7 | +62% | $22B | $15B | 1.3x | 21.3x | ||
| $235 | +75% | $20B | $31B | 1.4x | 6.7x | ||
| $209 | -1% | $20B | $23B | 6.4x | 20.8x | ||
| $104 | +139% | $20B | $21B | 6.4x | 48.5x | ||
| $99 | -12% | $19B | $26B | 3.2x | 9.6x | ||
 | $23 | +58% | $19B | $16B | 4.9x | 11.6x | ||
| $243 | -7% | $17B | $17B | 6.1x | 25.9x | ||
| $18 | +3% | $15B | $14B | 7.1x | 41.5x | ||
 | $18 | +21% | $15B | $18B | 2.8x | 11.2x | ||
 | $246 | -25% | $15B | $14B | 2.9x | 11.7x | ||
 | $24 | +23% | $14B | $14B | 10.5x | 31.1x | ||
 | $117 | -12% | $14B | $14B | 2.9x | 11.5x | ||
| $189 | +19% | $14B | $13B | 3.1x | 11.5x | ||
| $457 | +50% | $13B | $13B | 4.9x | 22.1x | ||
| $46 | -13% | $13B | $23B | 1.0x | 5.5x | ||
| $73 | -4% | $13B | $16B | 1.9x | 7.3x | ||
| $94 | +28% | $13B | $12B | 4.1x | 13.0x | ||
| $93 | +117% | $12B | $13B | 12.2x | (59.8x) | ||
 | $12 | 0% | $12B | $12B | 10.8x | 42.6x | ||
| $1 | +14% | $11B | $10B | 1.9x | 27.6x | ||
| $96 | -10% | $11B | $13B | 4.6x | 15.3x | ||
| $9 | -25% | $10B | $10B | 1.6x | 9.7x | ||
| $49 | +16% | $10B | $11B | 5.0x | 13.8x | ||
| $53 | +11% | $10B | $10B | 7.6x | 1270.8x | ||
| $4 | +7% | $9B | $13B | 2.1x | 12.8x | ||
 | $89 | -37% | $9B | $9B | 51.1x | 58.9x | ||
| $175 | +5% | $9B | $9B | 6.1x | 20.6x | ||
| $138 | -25% | $9B | $9B | 5.4x | 21.0x | ||
| $110 | -37% | $8B | $11B | 1.4x | 7.4x | ||
| $17 | -7% | $8B | $12B | 1.7x | 9.4x | ||
| $7 | +55% | $8B | $8B | 11.7x | 48.4x | ||
| $152 | -54% | $8B | $4B | 0.1x | 3.7x | ||
| $27 | +13% | $8B | $7B | 1.9x | 11.6x | ||
| $278 | +14% | $7B | $7B | 2.8x | 16.0x | ||
| $117 | -13% | $7B | $8B | 1.1x | 6.7x | ||
| $121 | +23% | $7B | $7B | 13.0x | (296.4x) | ||
| $10 | -4% | $7B | $6B | 2.7x | 10.5x | ||
| $81 | -8% | $7B | $8B | 5.8x | 13.4x | ||
| $3 | -4% | $6B | $8B | 3.2x | 12.1x | ||
| $290 | -14% | $6B | $6B | 7.8x | 28.6x | ||
| $8 | -11% | $6B | $6B | 7.9x | 17.8x | ||
 | $22 | -8% | $6B | $7B | 1.7x | 9.3x | ||
| $38 | -8% | $6B | $7B | 2.1x | 13.2x | ||
| $75 | +51% | $6B | $7B | 3.2x | 22.1x | ||
| $9 | -48% | $6B | $6B | 1.8x | 8.0x | ||
| $5 | +40% | $6B | $5B | — | — | ||
| $21 | +39% | $6B | $5B | 6.2x | 18.0x | ||
| $23 | +53% | $6B | $6B | 6.6x | 26.7x | ||
| $133 | +111% | $6B | $5B | 2.3x | 11.2x | ||
| $5 | +9% | $5B | $4B | 3.5x | 17.9x | ||
| $123 | -11% | $5B | $8B | 3.7x | 13.2x | ||
| $158 | +1% | $5B | $5B | 1.9x | 4.5x | ||
| $1 | +65% | $5B | $5B | 39.5x | (178.2x) | ||
| $76 | -22% | $5B | $5B | 3.5x | 9.5x | ||
| $26 | -30% | $5B | $6B | 5.7x | 13.5x | ||
| $147 | +119% | $5B | $5B | 8.0x | 32.5x | ||
| $141 | +10% | $5B | $5B | 5.0x | 21.8x | ||
| $29 | +71% | $5B | $5B | 1.9x | 13.8x | ||
| $354 | -19% | $5B | $5B | 5.5x | 13.1x | ||
| $44 | +37% | $5B | $4B | 0.8x | — | ||
| $26 | -56% | $5B | $4B | 6.3x | 11.4x | ||
| $34 | -13% | $5B | $5B | 11.5x | 28.4x | ||
| $3 | +56% | $5B | $5B | 5.1x | 17.0x | ||
| $77 | -28% | $5B | $5B | 3.2x | 12.8x | ||
| $3 | -7% | $5B | $5B | 1.4x | — | ||
 | $82 | -22% | $4B | $5B | 3.6x | 10.9x | ||
| $14 | +7% | $4B | $2B | 0.1x | (10.9x) | ||
| $15 | -26% | $4B | $5B | 3.2x | 12.7x | ||
| $206 | +27% | $4B | $4B | 5.0x | 18.3x | ||
| $56 | +65% | $4B | $4B | 3.8x | 17.6x | ||
| $21 | -19% | $4B | $4B | 11.3x | 44.4x | ||
| $53 | +70% | $4B | $4B | 4.7x | (36.2x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of last 12 months. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.